ARCHIVES

Preoperative Drug Combo Benefits HER-2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

Funding Opportunities (8-page issue).

April 25, 2003

Eight Firms Join AACR As Sustaining Members

April 25, 1997

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002